BioLineRx Ltd. (NASDAQ:BLRX) Q3 2025 Earnings Call Transcript November 24, 2025
BioLineRx Ltd. beats earnings expectations. Reported EPS is $-0.22, expectations were $-0.41.
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn over the call to Irina Koffler, Investor Relations. Irina, please go ahead.
Irina...
